NovoCure CEO Asaf Danziger's 2018 pay rises 6% to $4.6M
NovoCure reports 2018 executive compensation
By ExecPay News
Published: April 10, 2019
NovoCure reported fiscal year 2018 executive compensation information on April 10, 2019.
In 2018, six NovoCure executives received on average a compensation package of $3.6M, a 51% decrease compared to previous year.
Average pay of disclosed executives at NovoCure
Asaf Danziger, Chief Executive Officer, received $4.6M in total, which increased by 6% compared to 2017. 52% of Danziger's compensation, or $2.4M, was in option awards. Danziger also received $644K in non-equity incentive plan, $693K in salary, $588K in stock awards, as well as $286K in other compensation.
William F. Doyle, Chairman, received a compensation package of $4.6M, which decreased by 81% compared to previous year. 52% of the compensation package, or $2.4M, was in option awards.
Wilhelmus Groenhuysen, Chief Financial Officer, earned $3.5M in 2018, a 11% increase compared to previous year.
Eilon Kirson, Chief Scientific Officer, received $3.1M in 2018, which increases by 11% compared to 2017.
Pritesh Shah, Chief Commercial Officer, earned $3.1M in 2018.
Michael Ambrogi, Chief Operating Officer, received $2.6M in 2018, which increases by 16% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 10, 2019.